Next Article in Journal
Screening of Filamentous Fungi to Identify Biocatalysts for Lupeol Biotransformation
Next Article in Special Issue
The Structural Diversity of Deoxyribozymes
Previous Article in Journal
Heterocyclic Analogues of Xanthone and Xanthione. 1H-Pyrano[2,3-c:6,5-c]dipyrazol-4(7H)-ones and Thiones: Synthesis and NMR Data
Previous Article in Special Issue
Generation and Development of RNA Ligase Ribozymes with Modular Architecture Through “Design and Selection”
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 15
Issue 9
10.3390/molecules15096127
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene

by
Lifang Yang
1,2,
Zhongxin Lu
1,
Xiaoqian Ma
1,
Ya Cao
1,* and
Lun-Quan Sun
2,3,*
1
Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan 410078, China
2
Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410078, China
3
Department of Medical and Molecular Biosciences, University of Technology Sydney, Australia
*
Authors to whom correspondence should be addressed.
Molecules 2010, 15(9), 6127-6139; https://doi.org/10.3390/molecules15096127
Submission received: 18 June 2010 / Revised: 26 August 2010 / Accepted: 30 August 2010 / Published: 1 September 2010
(This article belongs to the Special Issue Catalytic Nucleic Acids)
Browse Figures
Versions Notes

Abstract

Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) has been known to have oncogenic properties during latent infection in nasopharyngeal carcinoma (NPC). Genetic manipulation of LMP1 expression may provide a novel strategy for the treatment of NPC. DNAzymes are synthetic, single-stranded DNA catalysts that can be engineered to bind and cleave the target mRNA of a disease-causing gene. By targeting the LMP1 mRNA, we successfully obtained a phosphorothioate-modified ‘‘10–23’’ DNAzyme namely DZ1, through screening a series of DNAzymes. DZ1 could significantly down-regulate the expression of LMP1 in NPC cells, inhibit cell proliferation, metastasis, promote apoptosis and enhance radiosensitivity of NPC through interfering signal pathways which are abnormally activated by LMP1, including NF-κB, AP-1 and STAT3 signal pathways. Together, interfering LMP1 signaling pathway could be a promising strategy to target the malignant phenotypes of NPC.
Keywords: LMP1; DNAzyme; NPC; targeted therapy LMP1; DNAzyme; NPC; targeted therapy

Share and Cite

MDPI and ACS Style

Yang, L.; Lu, Z.; Ma, X.; Cao, Y.; Sun, L.-Q. A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene. Molecules 2010, 15, 6127-6139. https://doi.org/10.3390/molecules15096127

AMA Style

Yang L, Lu Z, Ma X, Cao Y, Sun L-Q. A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene. Molecules. 2010; 15(9):6127-6139. https://doi.org/10.3390/molecules15096127

Chicago/Turabian Style

Yang, Lifang, Zhongxin Lu, Xiaoqian Ma, Ya Cao, and Lun-Quan Sun. 2010. "A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene" Molecules 15, no. 9: 6127-6139. https://doi.org/10.3390/molecules15096127

APA Style

Yang, L., Lu, Z., Ma, X., Cao, Y., & Sun, L.-Q. (2010). A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene. Molecules, 15(9), 6127-6139. https://doi.org/10.3390/molecules15096127

Article Metrics

Back to TopTop